Influence of 'nonhematological' doses of erythropoietin on lipid-carbohydrate metabolism and life quality in hemodialysis patients

Nephron. 1995;69(3):363-4. doi: 10.1159/000188501.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anemia / drug therapy
  • Carbohydrate Metabolism*
  • Dose-Response Relationship, Drug
  • Erythropoiesis / drug effects
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Lipid Metabolism*
  • Male
  • Quality of Life*
  • Renal Dialysis* / adverse effects

Substances

  • Erythropoietin